OTC Zyrtec Could Be A Star If Ads Show Efficacy Over Claritin – UCSF’s Soller

A successful Rx-to-OTC switch of Pfizer's non-sedating antihistamine Zyrtec will depend largely on the marketer's ability to communicate the drug's advantages over Claritin through consumer marketing efforts, according to Bill Soller, PhD, executive director, Center for Consumer Self Care, UCSF School of Pharmacy